INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 25 filers reported holding INHIBIKASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $299,000 | -33.3% | 403,000 | +33.0% | 0.01% | -7.1% |
Q1 2022 | $448,000 | +0.7% | 303,000 | 0.0% | 0.01% | -36.4% |
Q4 2021 | $445,000 | -22.7% | 303,000 | 0.0% | 0.02% | -50.0% |
Q3 2021 | $576,000 | -17.7% | 303,000 | +21.2% | 0.04% | +15.8% |
Q2 2021 | $700,000 | – | 250,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 937,500 | $853,000 | 1.18% |
HAMILTON LANE ADVISORS LLC | 165,635 | $151,000 | 0.06% |
Redmond Asset Management, LLC | 122,477 | $111,000 | 0.04% |
Retirement Planning Co of New England, Inc. | 59,069 | $53,000 | 0.04% |
CCG WEALTH MANAGEMENT, LLC | 20,000 | $18,000 | 0.01% |
Koshinski Asset Management, Inc. | 65,377 | $59,000 | 0.01% |
ZEKE CAPITAL ADVISORS, LLC | 93,800 | $85,000 | 0.01% |
K.J. Harrison & Partners Inc | 18,300 | $17,000 | 0.01% |
Warberg Asset Management LLC | 14,493 | $13,000 | 0.00% |
BLAIR WILLIAM & CO/IL | 179,000 | $163,000 | 0.00% |